New research shows potential treatment for Lewy body dementia

Lewy body dementia (LBD) is a type of dementia that gets worse over time. It is the second most common neurodegenerative disease after Alzheimer’s disease, but it can be hard to diagnose. It is a condition caused by abnormal protein deposits, called Lewy bodies, which damage areas of the brain and affect how it works. These changes impact movement, thinking, memory, mood, sleep, and more.

Banner Sun Health Research Institute is the first site globally to offer early access to a potential new treatment. We are enrolling those with dementia with Lewy bodies in an expanded access program, a pathway for patients to access investigational medicines when there are no other alternatives available. In this case, the investigational oral medication is Zervimesine, which showed promise in slowing the progression of dementia with Lewy body symptoms during a phase 2 clinical trial.

Dr. Parichita Choudhury, Cognitive and Behavioral Neurologist with Banner Sun Health Research Institute, joined “Arizona Horizon” to explain her research findings with Banner Sun Health.